Valuation: GENFIT

Market Cap 72Cr 84Cr 67Cr 62Cr 115.95Cr 8.06TCr 117.48Cr 797.43Cr 310.97Cr 4.05TCr 316.2Cr 309.32Cr 13TCr P/E 2026 *
37.2x
P/E 2027 * 95.8x
Enterprise Value 67Cr 78Cr 63Cr 57Cr 107.73Cr 7.49TCr 109.16Cr 740.92Cr 288.94Cr 3.76TCr 293.8Cr 287.4Cr 12TCr EV / Sales 2026 *
6.69x
EV / Sales 2027 * 5.28x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-5.27%
1 week-1.59%
Current month-6.82%
1 month+1.64%
3 months+57.74%
6 months+50.36%
Current year+159.45%
1 week 13.6
Extreme 13.6
14.82
1 month 12.74
Extreme 12.74
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/07/23 Buy

Director

5,300 0.0106%
07/07/23 Buy

Chief Executive Officer

10,000 0.0201%
07/07/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-5.27%-1.59%+275.27%+330.91% 84Cr
-0.76%+3.92%+2.76%+23.27% 5.16TCr
-1.07%+2.82%+465.96%+570.70% 4.49TCr
+1.47%+9.79%+35.92%+20.21% 4.28TCr
+1.44%+7.77%+19.38%+84.65% 4.26TCr
-0.93%-4.33%+16.18%+55.82% 3.18TCr
+1.32%+7.30%+33.89%+148.53% 1.73TCr
-0.60%+1.93% - - 1.66TCr
+0.03%+4.09%+9.17%+30.15% 1.48TCr
+1.28%+5.41%+82.40%+46.13% 1.41TCr
Average -0.16%+5.07%+104.55%+145.60% 2.77TCr
Weighted average by Cap. +0.37%+4.74%+99.94%+141.99%

Financials

2026 *2027 *
Net sales 10Cr 12Cr 9.38Cr 8.58Cr 16Cr 1.12TCr 16Cr 110.76Cr 43Cr 562.21Cr 44Cr 43Cr 1.86TCr 12Cr 14Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 137.13Cr 53Cr 696.03Cr 54Cr 53Cr 2.3TCr
Net income 2.29Cr 2.67Cr 2.14Cr 1.96Cr 3.68Cr 255.54Cr 3.73Cr 25Cr 9.86Cr 128.37Cr 10Cr 9.81Cr 424.59Cr 68L 79.38L 63.63L 58.24L 1.09Cr 76Cr 1.11Cr 7.52Cr 2.93Cr 38Cr 2.98Cr 2.92Cr 126.2Cr
Net Debt -5.11Cr -5.97Cr -4.78Cr -4.38Cr -8.22Cr -570.96Cr -8.33Cr -57Cr -22Cr -286.82Cr -22Cr -22Cr -948.68Cr -6.62Cr -7.73Cr -6.19Cr -5.67Cr -11Cr -739.13Cr -11Cr -73Cr -29Cr -371.3Cr -29Cr -28Cr -1.23TCr
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
24/26/24 13.66 -5.27% 1,47,515
21/26/21 €14.42 +2.27% 2,06,111
20/26/20 €14.10 -2.08% 3,07,015
19/26/19 €14.40 +4.96% 4,10,201
18/26/18 €13.72 -1.15% 2,03,967
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.42EUR
Average target price
15.90EUR
Spread / Average Target
+10.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock